胡晓宇, 吴银根. 温阳抗寒汤联合西药治疗慢性支气管炎急性发作患者的临床观察[J]. 实用临床医药杂志, 2021, 25(1): 58-61. DOI: 10.7619/jcmp.20200864
引用本文: 胡晓宇, 吴银根. 温阳抗寒汤联合西药治疗慢性支气管炎急性发作患者的临床观察[J]. 实用临床医药杂志, 2021, 25(1): 58-61. DOI: 10.7619/jcmp.20200864
HU Xiaoyu, WU Yingen. Clinical Observation of Wenyang Kanghan Decoction combined with western medicines in treatment of patients with acute exacerbation of chronic bronchitis[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 58-61. DOI: 10.7619/jcmp.20200864
Citation: HU Xiaoyu, WU Yingen. Clinical Observation of Wenyang Kanghan Decoction combined with western medicines in treatment of patients with acute exacerbation of chronic bronchitis[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 58-61. DOI: 10.7619/jcmp.20200864

温阳抗寒汤联合西药治疗慢性支气管炎急性发作患者的临床观察

Clinical Observation of Wenyang Kanghan Decoction combined with western medicines in treatment of patients with acute exacerbation of chronic bronchitis

  • 摘要: 目的 探讨温阳抗寒汤联合西药治疗肾阳虚型慢性支气管炎急性发作患者的效果。 方法 将114例慢性支气管炎急性发作患者随机分为对照组(n=59)和观察组(n=55), 对照组给予常规西药治疗,观察组在对照组基础上给予温阳抗寒汤。比较2组临床疗效、中医证候评分、莱塞斯特咳嗽量表(LCQ)评分; 分析2组白细胞介素-2受体(IL-2R)、白细胞介素-6(IL-6)、白细胞介素-8(IL-8)、白细胞介素-10(IL-10)的水平变化。 结果 观察组总有效率为90.91%, 高于对照组的86.44%, 差异有统计学意义(P< 0.05)。治疗后,观察组中医证候评分和IL-2R、IL-6、IL-8水平均低于对照组,差异有统计学意义(P< 0.05); 观察组社会、心理、生理得分及LCQ总分均高于对照组,差异有统计学意义(P< 0.05)。 结论 温阳抗寒汤联合西药对肾阳虚型慢性支气管炎急性发作患者疗效较佳,可改善患者免疫水平,提高生活质量。

     

    Abstract: Objective To explore the effect of Wenyang Kanghan Decoction combined with western medicine in treatment of patients with acute exacerbation of chronic bronchitis. Methods A total of 114 patients with acute onset of chronic bronchitis were randomly divided into control group (n=59) and observation group (n=55). The control group was given conventional western medicine treatment, and the treatment group was given Wenyang Kanghan Decoction on the basis of the control group. Clinical efficacy, TCM syndrome score and Leicester cough questionnaire (LCQ) score were compared in the two groups, and the changes of interleukin-2 receptor (IL-2R), interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) levels in the two groups were analyzed. Results The total effective rate in the treatment group was 90.91%, which significantly higher than 86.44% in the control group (P< 0.05). After treatment, TCM syndrome score and IL-2R, IL-6 and IL-8 levels in the treatment group were significantly lower than those in the control group (P< 0.05); the social, psychological and physiological scores as well as LCQ total score of the treatment group were significantly higher than those of the control group (P< 0.05). Conclusion Wenyang Kanghan Decoction combined with western medicine has a better effect in patients with acute exacerbation of chronic bronchitis differentiated as kidney-yang deficiency syndrome, which can improve the immune level of patients and enhance the quality of life.

     

/

返回文章
返回